News Image

HALOZYME THERAPEUTICS INC (NASDAQ:HALO), a strong growth stock, setting up for a breakout.

By Mill Chart

Last update: Apr 18, 2025

Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if HALOZYME THERAPEUTICS INC (NASDAQ:HALO) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted HALOZYME THERAPEUTICS INC showing up in our growth with base formation screen, so it may be worth spending some more time on it.


High Growth setup stocks image

A Closer Look at Growth for HALO

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. HALO has received a 8 out of 10:

  • HALO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.16%, which is quite impressive.
  • HALO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.12% yearly.
  • Looking at the last year, HALO shows a very strong growth in Revenue. The Revenue has grown by 22.46%.
  • The Revenue has been growing by 38.95% on average over the past years. This is a very strong growth!
  • The Earnings Per Share is expected to grow by 16.06% on average over the next years. This is quite good.
  • HALO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.27% yearly.

Health Assessment of HALO

ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. HALO was assigned a score of 8 for health:

  • HALO has an Altman-Z score of 4.73. This indicates that HALO is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.73, HALO belongs to the top of the industry, outperforming 81.34% of the companies in the same industry.
  • The Debt to FCF ratio of HALO is 3.21, which is a good value as it means it would take HALO, 3.21 years of fcf income to pay off all of its debts.
  • HALO's Debt to FCF ratio of 3.21 is amongst the best of the industry. HALO outperforms 94.01% of its industry peers.
  • A Current Ratio of 7.80 indicates that HALO has no problem at all paying its short term obligations.
  • HALO's Current ratio of 7.80 is fine compared to the rest of the industry. HALO outperforms 73.59% of its industry peers.
  • A Quick Ratio of 6.78 indicates that HALO has no problem at all paying its short term obligations.
  • HALO has a better Quick ratio (6.78) than 68.13% of its industry peers.

A Closer Look at Profitability for HALO

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. HALO scores a 8 out of 10:

  • HALO's Return On Assets of 21.52% is amongst the best of the industry. HALO outperforms 98.94% of its industry peers.
  • HALO has a better Return On Equity (122.06%) than 99.47% of its industry peers.
  • HALO has a Return On Invested Capital of 23.00%. This is amongst the best in the industry. HALO outperforms 99.12% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for HALO is above the industry average of 14.25%.
  • The last Return On Invested Capital (23.00%) for HALO is above the 3 year average (17.81%), which is a sign of increasing profitability.
  • The Profit Margin of HALO (43.74%) is better than 99.12% of its industry peers.
  • HALO has a better Operating Margin (54.32%) than 99.82% of its industry peers.
  • HALO has a better Gross Margin (84.30%) than 86.97% of its industry peers.
  • In the last couple of years the Gross Margin of HALO has grown nicely.

Looking at the Setup

ChartMill also assigns a Setup Rating to each stock. This rating, on a scale of 0 to 10, reflects the degree of consolidation observed based on short-term technical indicators. Currently, HALO exhibits a 7 setup rating, indicating its consolidation status in recent days and weeks.

Besides having an excellent technical rating, HALO also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 59.13. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 58.78, a Stop Loss order could be placed below this zone.

More Strong Growth stocks can be found in our Strong Growth screener.

For an up to date full fundamental analysis you can check the fundamental report of HALO

Check the latest full technical report of HALO for a complete technical analysis.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

HALOZYME THERAPEUTICS INC

NASDAQ:HALO (7/1/2025, 2:31:07 PM)

52.825

+0.8 (+1.55%)



Find more stocks in the Stock Screener

HALO Latest News and Analysis

ChartMill News Image3 days ago - ChartmillHALOZYME THERAPEUTICS INC (NASDAQ:HALO) - A Strong Candidate for Affordable Growth Investors

HALOZYME THERAPEUTICS (NASDAQ:HALO) offers strong growth, solid profitability, and reasonable valuation, making it a standout in affordable growth investing.

ChartMill News Image6 days ago - ChartmillHALOZYME THERAPEUTICS INC (NASDAQ:HALO) – A Biotech Stock With Strong Fundamentals and Attractive Valuation

HALOZYME THERAPEUTICS (NASDAQ:HALO) offers a rare mix of strong growth, profitability, and financial health at an attractive valuation, making it a standout in the biotech sector.

ChartMill News Image14 days ago - ChartmillHALOZYME THERAPEUTICS INC (NASDAQ:HALO) – A Strong Growth Stock with Technical Breakout Potential

HALOZYME THERAPEUTICS INC (NASDAQ:HALO) shows strong growth fundamentals and a potential technical breakout, making it a stock to watch in the biotech sector.

Follow ChartMill for more